Linked Data API

Show Search Form

Search Results

1580822
registered interest false remove filter
date less than 2023-01-25more like thismore than 2023-01-25
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Voluntary Scheme for Branded Medicines Pricing and Access more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, whether his Department has received evidence from the life sciences industry of the impact on UK R&D investment and potential increases in payment rates under the voluntary and statutory schemes for branded medicines; and if it will make a statement. more like this
tabling member constituency South Basildon and East Thurrock more like this
tabling member printed
Stephen Metcalfe more like this
uin 132374 more like this
answer
answer
is ministerial correction true more like this
date of answer less than 2023-02-01more like thismore than 2023-02-01
answer text <p>The Department has been consulting on a proposed update to the <ins class="ministerial">s</ins><del class="ministerial">S</del>tatutory <ins class="ministerial">s</ins><del class="ministerial">S</del>cheme for branded medicines and the life sciences industry has been able to <ins class="ministerial">give evidence</ins><del class="ministerial">express its views</del> as part of this consultation process.</p><p><del class="ministerial">In considering the responses, the Department is carefully taking into account any evidence submitted on potential impacts for the United Kingdom life sciences sector.</del></p><p>The Government remains firmly committed to the <ins class="ministerial">s</ins><del class="ministerial">S</del>tatutory and <ins class="ministerial">v</ins><del class="ministerial">V</del>oluntary schemes for branded medicines and to working with the pharmaceutical industry to deliver on the ambitions set out in the Life Sciences Vision to create an environment that facilitates innovation for the development of medicines in the UK.</p>
answering member constituency Colchester more like this
answering member printed Will Quince more like this
question first answered
less than 2023-02-01T11:22:27.7Zmore like thismore than 2023-02-01T11:22:27.7Z
question first ministerially corrected
less than 2023-02-01T11:38:17.323Zmore like thismore than 2023-02-01T11:38:17.323Z
answering member
4423
label Biography information for Will Quince more like this
previous answer version
51971
answering member constituency Colchester more like this
answering member printed Will Quince more like this
answering member
4423
label Biography information for Will Quince more like this
tabling member
4092
label Biography information for Stephen Metcalfe more like this